Literature DB >> 15797999

Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function.

Lénaïck Détivaud1, Elizabeta Nemeth, Karim Boudjema, Bruno Turlin, Marie-Bérengère Troadec, Patricia Leroyer, Martine Ropert, Sylvie Jacquelinet, Brice Courselaud, Tomas Ganz, Pierre Brissot, Olivier Loréal.   

Abstract

Hepcidin, a key regulator of iron metabolism, is synthesized by the liver. Hepcidin binds to the iron exporter ferroportin to regulate the release of iron into plasma from macrophages, hepatocytes, and enterocytes. We analyzed liver samples from patients undergoing hepatic surgery for cancer or receiving liver transplants and analyzed correlations between clinical parameters and liver hepcidin mRNA and urinary hepcidin concentrations. Despite the many potential confounding influences, urinary hepcidin concentrations significantly correlated with hepatic hepcidin mRNA concentrations, indicating that hepcidin quantification in urine is a valid approach to evaluate hepcidin expression. Moreover, we found in humans that hepcidin levels correlated with hepatic iron stores and hemoglobin levels and may also be affected by hepatic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15797999     DOI: 10.1182/blood-2004-12-4855

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

Review 1.  Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver.

Authors:  Elmar Aigner; Günter Weiss; Christian Datz
Journal:  World J Hepatol       Date:  2015-02-27

2.  Nitrative and oxidative modifications of enolase are associated with iron in iron-overload rats and in vitro.

Authors:  Naihao Lu; Xueli Li; Jinyang Li; Wenjing Xu; Hailing Li; Zhonghong Gao
Journal:  J Biol Inorg Chem       Date:  2010-12-23       Impact factor: 3.358

3.  Identification and expression analysis of hepcidin-like cDNAs from pigeon (Columba livia).

Authors:  Yu Ming Fu; Su Ping Li; Yue Feng Wu; Yan Zhong Chang
Journal:  Mol Cell Biochem       Date:  2007-07-10       Impact factor: 3.396

4.  [Complications after allogeneic bone marrow and stem cell transplantation].

Authors:  E Wollmer; A Neubauer
Journal:  Internist (Berl)       Date:  2014-05       Impact factor: 0.743

5.  Anaemia in patients with cancer: role of inflammatory activity on iron metabolism and severity of anaemia.

Authors:  M L V Jacober; R L Mamoni; C S P Lima; B L Dos Anjos; H Z W Grotto
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

6.  Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates.

Authors:  Jason S Troutt; Anthony M Butterfield; Robert J Konrad
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

Review 7.  Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease?

Authors:  Duygu Dee Harrison-Findik
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

8.  Proinflammatory state, hepcidin, and anemia in older persons.

Authors:  Luigi Ferrucci; Richard D Semba; Jack M Guralnik; William B Ershler; Stefania Bandinelli; Kushang V Patel; Kai Sun; Richard C Woodman; Nancy C Andrews; Robert J Cotter; Tomas Ganz; Elizabeta Nemeth; Dan L Longo
Journal:  Blood       Date:  2010-01-15       Impact factor: 22.113

9.  Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin.

Authors:  Damien R Ashby; Daniel P Gale; Mark Busbridge; Kevin G Murphy; Neill D Duncan; Tom D Cairns; David H Taube; Stephen R Bloom; Frederick W K Tam; Richard Chapman; Patrick H Maxwell; Peter Choi
Journal:  Haematologica       Date:  2009-10-14       Impact factor: 9.941

10.  An insight into the relationships between hepcidin, anemia, infections and inflammatory cytokines in pediatric refugees: a cross-sectional study.

Authors:  Sarah Cherian; David A Forbes; Angus G Cook; Frank M Sanfilippo; Erwin H Kemna; Dorine W Swinkels; David P Burgner
Journal:  PLoS One       Date:  2008-12-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.